Business NewsPR NewsWire • Oasmia Pharmaceutical AB, Sweden - Listing Prospectus: NASDAQ OMX Stockholm

Oasmia Pharmaceutical AB, Sweden - Listing Prospectus: NASDAQ OMX Stockholm

Oasmia Pharmaceutical AB, Sweden - Listing Prospectus: NASDAQ OMX Stockholm

UPPSALA, Sweden, July 15, 2010 /PRNewswire-FirstCall/ -- - A Number of Promising New Product Candidates for Cancer Treatment, Within Both Human and Veterinary Oncology ABOUT OASMIA Oasmia is developing a new generation of drugs with emphasis on human and veterinary oncology. Our

View More : http://www.prnewswire.com/news-releases/oasmia-pharmaceutical-ab-sweden---listing-prospectus-nasdaq-omx-stockholm-984871...
Releted News by prnewswire
Open Road Tolling set to Begin on SR 874 and SR 878
Logo Acquires Off-Cable Syndication Rights to Groundbreaking Golden GlobeĀ® Award-Winning Drama Series 'Nip/Tuck'
Oasmia Pharmaceutical AB, Sweden - Listing Prospectus: NASDAQ OMX Stockholm
Brand New Slot Launches With GBP1.5 Million Jackpot at Jackpotjoy.com!
North Georgia's Best Mountain Venue for Meetings & Events Brasstown Valley Resort & Spa